Erika Hamilton, MD
Specialities
- Breast cancer
- Clinical trials and research advancements
- Cancers related to women’s health
- Early-phase drug development
Education
Medical Degree: University of North Carolina at Chapel Hill
Residency: University of North Carolina at Chapel Hill
Fellowship: Duke University
Location
335 24th Avenue North, Suite 200
Nashville, Tennessee 37203
Phone: 615-329-7640
Fax: 615-234-7723
Language
English
Biography
Dr. Hamilton is a board-certified medical oncologist at SCRI Oncology Partners and the director of breast cancer research at SCRI. Dr. Hamilton is an expert who is highly recognized in her field—she has been named American Society of Clinical Oncology (ASCO) Scientific Chair for 2025, the 2023-2025 Scientific Committee co-chair of the European Society for Medical Oncology Breast Cancer Meeting, and serves on ASCO’s Cancer Research Committee. She is also the associate editor for Clinical Breast Cancer.
Philosophy
As the daughter of a breast cancer survivor, Dr. Hamilton understands the importance of compassionate, individualized cancer care. She strives to empower her patients by listening to their goals and preferences for their health and creating personalized treatment plans to best suit each individual’s needs.
Relevant Research
Journal of Clinical Oncology
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Journal of Clinical Oncology
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
Annals of Oncology
Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial